Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 26 results.
User Information
Export Records
  1. 1.   Escherichia coli grown in inexpensive conical flat-bottom polypropylene tubes produce a high level of pUC vector
  2. Marquez,Mayra; Chen,Qian; Cachaco,Silvia; Yang,Jun; Sui,Hongyan; Imamichi,Tomozumi
  3. Journal of Microbiological Methods. 2024, Jul 14; 224: 106990.
  1. 2.   Lessons learned: establishing a CLIA-equivalent laboratory for targeted mass spectrometry assays - navigating the transition from research to clinical practice
  2. Han, Chia-Li; Lai, Chi-Ting; Reyes, Aaron James; Yang, Hao-Chin; Lu, Jin-Ying; Shih, Shyang-Rong; Chen, Kuen-Yuan; Hoofnagle, Andrew N; Yu, Sung-Liang; Bocik, William; Hiltke, Tara; Chiu, Huan-Chi; Wan, Ching-Yi; Rodriguez, Henry; Zhang, Victoria; Chen, Yu-Ju
  3. Clinical Proteomics. 2024, Feb 22; 21(1): 12.
  1. 3.   Structure of Helicobacter pylori dihydroneopterin aldolase suggests a fragment-based strategy for isozyme-specific inhibitor design
  2. Shaw,Gary; Fan,Lixin; Cherry,Scott; Shi,Genbin; Tropea, Joseph E; Ji,Xinhua
  3. Current Research in Structural Biology. 2023, Jan 30; 5: 100095.
  1. 4.   Exploration of Ultralarge Compound Collections for Drug Discovery
  2. Warr, Wendy A; Nicklaus,Marc; Nicolaou, Christos A; Rarey, Matthias
  3. Journal of Chemical Information and Modeling. 2022, Apr 14;
  1. 5.   The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines
  2. Condit, Richard C; Kim, Denny; Robertson, James S; Excler, Jean-Louis; Gurwith, Marc; Monath, Thomas P; Pavlakis,George; Fast, Patricia E; Smith, Jonathan; Smith, Emily R; Chen, Robert T; Kochhar, Sonali
  3. Vaccine. 2020, NOV 17; 38(49): 7708-7715.
  1. 6.   The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines
  2. Condit, Richard C; Kim, Denny; Robertson, James S; Excler, Jean-Louis; Gurwith, Marc; Monath, Thomas P; Pavlakis,George; Fast, Patricia E; Smith, Jonathan; Smith, Emily R; Chen, Robert T; Kochhar, Sonali
  3. Vaccine. 2020, Sep 06; pii: S0264-410X(20)31030-6.
  1. 7.   The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines
  2. Condit, Richard C; Kim, Denny; Robertson, James S; Excler, Jean-Louis; Gurwith, Marc; Monath, Thomas P; Pavlakis,George; Fast, Patricia E; Smith, Jonathan; Smith, Emily R; Chen, Robert T; Kochhar, Sonali
  3. Vaccine. 2020, Sep 06; pii: S0264-410X(20)31030-6.
  1. 8.   Patterns of signs, symptoms and laboratory values associated with Zika, dengue and undefined acute illnesses in a dengue endemic region: secondary analysis of a prospective cohort study in southern México
  2. Hunsberger, Sally; Ortega-Villa, Ana M; Powers,John; Rincón León, Héctor Armando; Sosa, Sandra Caballero; Ruiz Hernández, Emilia; Nájera Cancino, José Gabriel; Nason, Martha; Lumbard,Keith; Sepulveda, Jesús; Guerra de Blas, Paola Del Carmen; Ruiz-Palacios, Guillermo; Belaunzarán-Zamudio, Pablo F
  3. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020, SEP; 98: 241-+.
  1. 9.   The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines
  2. Kim, Denny; Robertson, James S.; Excler, Jean-Louis; Condit, Richard C.; Fast, Patricia E.; Gurwith, Marc; Pavlakis,George; Monath, Thomas P.; Smith, Jonathan; Wood, David; Smith, Emily R.; Chen, Robert T.; Kochhar, Sonali
  3. Vaccine. 2020, JUL 22; 38(34): 5556-5561.
  1. 10.   Assessing the Value of Team Science A Study Comparing Center- and Investigator-Initiated Grants
  2. Hall, K. L.; Stokols, D.; Stipelman, B. A.; Vogel, A. L.; Feng, A.; Masimore, B.; Morgan, G.; Moser, R. P.; Marcus, S. E.; Berrigan, D.
  3. American Journal of Preventive Medicine. 2012, Feb; 42(2): 157-163.
  1. 11.   Interlaboratory comparison of size and surface charge measurements on nanoparticles prior to biological impact assessment
  2. Roebben, G.; Ramirez-Garcia, S.; Hackley, V. A.; Roesslein, M.; Klaessig, F.; Kestens, V.; Lynch, I.; Garner, C. M.; Rawle, A.; Elder, A.; Colvin, V. L.; Kreyling, W.; Krug, H. F.; Lewicka, Z. A.; McNeil, S.; Nel, A.; Patri, A.; Wick, P.; Wiesner, M.; Xia, T.; Oberdorster, G.; Dawson, K. A.
  3. Journal of Nanoparticle Research. 2011, Jul; 13(7): 2675-2687.
  1. 12.   PTSD Treatment of African American Adults in Primary Care: The Gap Between Current Practice and Evidence-Based Treatment Guidelines
  2. Graves, R. E.; Freedy, J. R.; Aigbogun, N. U.; Lawson, W. B.; Mellman, T. A.; Alim, T. N.
  3. Journal of the National Medical Association. 2011, Jul; 103(7): 585-593.
  1. 13.   Grid-Enabled Measures Using Science 2.0 to Standardize Measures and Share Data
  2. Moser, R. P.; Hesse, B. W.; Shaikh, A. R.; Courtney, P.; Morgan, G.; Augustson, E.; Kobrin, S.; Levin, K. Y.; Helba, C.; Garner, D.; Dunn, M.; Coa, K.
  3. American Journal of Preventive Medicine. 2011, May; 40(5): S134-S143.
  1. 14.   Evaluation of a library outreach program to research labs
  2. Brandenburg, M. D.; Doss, A.; Frederick, T. E.
  3. Medical reference services quarterly. 2010, Jul; 29(3): 249-59.
  1. 15.   Immunologic and Virologic Events in Early HIV Infection Predict Subsequent Rate of Progression
  2. Ganesan, A.; Chattopadhyay, P. K.; Brodie, T. M.; Qin, J.; Gu, W. J.; Mascola, J. R.; Michael, N. L.; Follmann, D. A.; Roederer, M.; Infect Dis Clinical Res Program, H. I.
  3. Journal of Infectious Diseases. 2010, Jan; 201(2): 272-284.
  1. 16.   MouseIndelDB: a database integrating genomic indel polymorphisms that distinguish mouse strains
  2. Akagi, K.; Stephens, R. M.; Li, J. F.; Evdokimov, E.; Kuehn, M. R.; Volfovsky, N.; Symer, D. E.
  3. Nucleic Acids Research. 2010, Jan; 38(Database issue): D600-D606.
  1. 17.   Extensive variation between inbred mouse strains due to endogenous L1 retrotransposition
  2. Akagi, K.; Li, J. F.; Stephens, R. M.; Volfovsky, N.; Symer, D. E.
  3. Genome Research. 2008 18(6): 869-880.
  1. 18.   Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy
  2. Hare, C. B.; Mellors, J.; Krambrink, A.; Su, Z. H.; Skiest, D.; Margolis, D. M.; Patel, S. S.; Barnas, D.; Frenkel, L.; Coombs, R. W.; Aweeka, F.; Morse, G. D.; Haas, D. W.; Boltz, V.; Palmer, S.; Coffin, J.; Havlir, D. V.
  3. Clinical Infectious Diseases. 2008 47(3): 421-424.
  1. 19.   Genetic polymorphisms and spontaneous preterm birth
  2. Gibson, C. S.; MacLennan, A. H.; Dekker, G. A.; Goldwater, P. N.; Dambrosia, J. M.; Munroe, D. J.; Tsang, S.; Stewart, C.; Nelson, K. B.
  3. Obstetrics and Gynecology. 2007, Feb; 109(2): 384-391.
  1. 20.   International collaboration in drug discovery and development from natural sources
  2. Cragg, G. M.; Newman, D. J.
  3. Pure and Applied Chemistry. 2005, NOV; 77(11): 1923-1942.
  1. 21.   Biodiversity: A continuing source of novel drug leads
  2. Cragg, G. M.; Newman, D. J.
  3. Pure and Applied Chemistry. 2005, JAN; 77(1): 7-24.
  1. 22.   Academia-industry collaboration: An integral element for building "omic" resources
  2. Hill, D. E.; Brasch, M. A.; del Campo, A. A.; Doucette-Stamm, L.; Garrels, J. I.; Glaven, J.; Hartley, J. L.; Hudson, J. R.; Moore, T.; Vidal, M.
  3. Genome Research. 2004, OCT; 14(10B): 2010-2014.
  1. 23.   Chromosome painting in the long-tailed field mouse provides insights into the ancestral murid karyotype
  2. Stanyon, R.; Yang, F.; Morescalchi, A. M.; Galleni, L.
  3. Cytogenetic and Genome Research. 2004 105(2-4): 406-411.
  1. 24.   Helicobacter typhlonius sp nov., a novel murine urease-negative Helicobacter species
  2. Franklin, C. L.; Gorelick, P. L.; Riley, L. K.; Dewhirst, F. E.; Livingston, R. S.; Ward, J. M.; Beckwith, C. S.; Fox, J. G.
  3. Journal of Clinical Microbiology. 2001 39(11): 3920-3926.
  1. 25.   Natural product drug discovery in the next millennium
  2. Cragg, G. M.; Newman, D. J.
  3. Pharmaceutical Biology. 2001 39(Suppl. S): 8-17.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel